Abstract
It is indisputable that the ability to measure accurately the concentrations of cardiac drugs in biological fluids has greatly improved their use in clinical practice. The need for drug level measurements in research is obvious. Measurement of drug bioavailability, drug pharmacokinetics, effects of disease, patient age, drug interactions etc. have to be investigated to define dosage regimes of new drugs. However it does not follow that the measurement of cardiac drug levels in individuals will enhance patient treatment.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Nation, R.L., Triggs, E.J. and Selig, M. (1977) Lignocaine kinetics in cardiac patients. Br. J. Clin. Pharmacol., 4, 439–48.
Holt, D.W., Walsh, A.C., Curry, P.V. and Tynan, M. (1979) Paediatric use of mexiletine and disopyramide. Br. Med. J., 2, 1476–7.
Johnston, A., Henry, J.A., Warrington, S.J. and Hamer, N.A.J. (1980) Pharmacokinetics of oral disopyramide phosphate in patients with renal failure. Br. J. Clin. Pharmacol., 10, 245–8.
Heagerty, A.M., Donovan, M.A., Castleden, C.M. Pohl, J.F., Patel, L. and Hedges, A. (1981) Influence of cimetidine on the pharmacokinetics of propranolol. Br. Med. J., 282, 1917–18.
Lancet (1984) Polymorphic drug oxidation-much ado about nothing? Lancet, 2, 1337.
Aitio, M.-L., Mansury, L., Tala, E., Haataja, M. and Aitio, A. (1981) The effect of enzyme induction on the metabolism of disopyramide in man. Br. J. Clin Pharmacol., 11, 279–85.
Clarke, E. G. C. (1969) Isolation and Identification of Drugs. Vol. 1, Pharmaceutical Press, London.
Clarke, E.G.C. (1975) Isolation and Identification of Drugs. Vol. 2, Pharmaceutical Press, London.
Fitzgerald, J.D. and Scales, B. (1968) Effect of a new adrenergic beta-blocking agent (ICI-50 172) on heart rate in relation to its blood levels. Int. J. Clin. Pharmacol., 1, 467–74.
Shand, D.G., Nuckolls, E.M. and Dates, J.A. (1970) Plasma propranolol levels in adults with obervations in four children. Clin. Pharm. Ther., 11, 112–20.
Pacha, W.L. (1969) A method for the fluorimetric determination of 4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB46), a beta-blocking agent, in plasma and urine. Experientia, 25, 802–3.
Gupta, R.N., Eng. F., Lewis, D. and Kumana, C. (1979) Fluorescence photometric determination of disopyramide and mono-N-dealkylated disopyramide in plasma after separation by thin layer chromatography. Anal. Chem., 51, 455–8.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Johnston, A. (1987). Techniques for the blood level measurement of cardiac drugs and their application. In: Hamer, J. (eds) Drugs for Heart Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-3294-5_13
Download citation
DOI: https://doi.org/10.1007/978-1-4899-3294-5_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-412-26540-2
Online ISBN: 978-1-4899-3294-5
eBook Packages: Springer Book Archive